OpGen, Inc. (NASDAQ:OPGN – Get Free Report)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.02 and traded as high as $1.25. OpGen shares last traded at $1.25, with a volume of 962 shares trading hands.
Analysts Set New Price Targets
Separately, StockNews.com began coverage on shares of OpGen in a research note on Friday. They set a “sell” rating for the company.
Get Our Latest Analysis on OpGen
OpGen Trading Up 1.6 %
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
See Also
- Five stocks we like better than OpGen
- 3 Small Caps With Big Return Potential
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What Are Trending Stocks? Trending Stocks Explained
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is the Hang Seng index?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
